John received his BS from Boston College, where he majored in biology and was a member of the van Opijnen Lab.  In the Beroukhim Lab, John’s main research focus was on the role of MYB-QKI fusions as drivers of angiocentric gliomas, a subtype of pediatric low-grade gliomas.  John was also involved in research addressing the presence of clustered deletions near the BRD4 promoter and how this influences BRD4 expression in various cancer types. John is currently a clinical bioinformatics analyst at LinkedIn.

Favorite quote: “The only way to make sense out of change is to plunge into it, move with it, and join the dance.” Alan Watts